中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
4期
522-524
,共3页
脑梗死%超敏C反应蛋白%S100蛋白%桂哌齐特
腦梗死%超敏C反應蛋白%S100蛋白%桂哌齊特
뇌경사%초민C반응단백%S100단백%계고제특
Cerebral infarction%High sensitive C-reactive protein%S100B%Gui piperazine strange maleate
目的 探讨桂哌齐特对急性脑梗死患者血清超敏C反应蛋白(hs-CRP)和S100B蛋白(S100B)的影响.方法 将90例急性脑梗死患者随机分为对照组45例和治疗组45例.对照组采用常规治疗,治疗组加用桂哌齐特注射液治疗,两组均治疗14 d.治疗前后测定患者血清hs-CRP和S100B.结果 治疗组总有效率为93.3％,高于对照组的84.4％(x2 =4.0125,P＜0.05).两组治疗后均可明显降低血清hs-CRP和S100B(均P＜0.05),并且治疗组降低更明显(均P＜0.05).结论 桂哌齐特通过减轻炎性反应而缓解急性脑梗死患者的病情.
目的 探討桂哌齊特對急性腦梗死患者血清超敏C反應蛋白(hs-CRP)和S100B蛋白(S100B)的影響.方法 將90例急性腦梗死患者隨機分為對照組45例和治療組45例.對照組採用常規治療,治療組加用桂哌齊特註射液治療,兩組均治療14 d.治療前後測定患者血清hs-CRP和S100B.結果 治療組總有效率為93.3％,高于對照組的84.4％(x2 =4.0125,P＜0.05).兩組治療後均可明顯降低血清hs-CRP和S100B(均P＜0.05),併且治療組降低更明顯(均P＜0.05).結論 桂哌齊特通過減輕炎性反應而緩解急性腦梗死患者的病情.
목적 탐토계고제특대급성뇌경사환자혈청초민C반응단백(hs-CRP)화S100B단백(S100B)적영향.방법 장90례급성뇌경사환자수궤분위대조조45례화치료조45례.대조조채용상규치료,치료조가용계고제특주사액치료,량조균치료14 d.치료전후측정환자혈청hs-CRP화S100B.결과 치료조총유효솔위93.3％,고우대조조적84.4％(x2 =4.0125,P＜0.05).량조치료후균가명현강저혈청hs-CRP화S100B(균P＜0.05),병차치료조강저경명현(균P＜0.05).결론 계고제특통과감경염성반응이완해급성뇌경사환자적병정.
Objective To explore the influence of Gui piperazine strange maleate on the high sensitive C-reactive protein(hs-CRP) and S100B in the serum of patients with acute cerebral infarction.Methods 90 patients with acute cerebral infarction were randomly divided into two groups,the control group(45 cases) and the treatment group (45 cases).The patients in the control group were treated through the conventional treatment,while the patients in the treatment group were treated plus Gui piperazine strange maleate.They were treated for fourteen days.The hs-CRP and S100B in the serum were detected before and after treatment.Results The total effective rates were 93.3％ in the treatment group and 84.4％ in the control group.There was a significant difference between two groups(x2 =4.0125,P ＜ 0.05).The hs-CRP and S100B were decreased after treatment in both groups (all P ＜ 0.05),and there was a significant difference between two groups after treatment (all P ＜ 0.05).Conclusion Gui piperazine strange maleate can improve acute cerebral infarction through mitigating inflammation.
